Prenatal screens included BT A positive, antibody negative, RPR nonreactive, rubella immune, hepatitis surface antigen negative, GBS positive.
Mother was admitted for preterm labor on [**2181-2-9**].
She was treated with magnesium sulfate and betamethasone.
The infant was delivered by cesarean section secondary to premature rupture of membranes, unstoppable preterm labor and breech presentation of this infant.
She received blow-by O2 briefly, then was taken to the neonatal intensive care unit for further management.
Spine midline with no sacral dimple noted.
The    infant was intubated and treated with Survanta for a total    of 2 doses.
She weaned to CPAP at 48 hours of age, and was on    and off CPAP until successfully weaning to nasal cannula by    day of life 15.
She did develop mild chronic lung disease,    requiring low nasal cannula oxygen until day of life 60, when    she successfully transitioned to room air.
She was    empirically treated with caffeine citrate for management    of apnea and bradycardia of prematurity.
[**Known lastname 41356**] was treated with indomethacin for    presumed PDA.
She advanced to full    enteral feedings by day of life 13, and maximum  enteral    intake was 150 cc/kg/day of breast milk 26 calories with    ProMod.
She was treated with    phototherapy for approximately 1 week.
Infant has    not required any blood transfusions during this hospital    course.
She is    receiving ferrous sulfate supplementation of 4 mg/kg,    which equals 0.5 ml p.o.
Blood culture remained    negative at 48 hours, at which time ampicillin and    gentamicin were discontinued.
Ophthalmology - The infant was most recently    examined on [**2181-4-16**], revealing right eye with immature    zone 2, left eye stage 1 zone 3 one to two clock hours,    with recommended followup in 2 weeks with Dr. [**Last Name (STitle) **].
FEEDS AT DISCHARGE:  Continue ad lib feeding of breast milk reconstituted to 24 calories with Similac powder.
MEDICATIONS:  Tri-Visol 1 ml p.o.
daily, ferrous sulfate 0.5 mg p.o.
IMMUNIZATIONS RECEIVED:  She received hepatitis B vaccine on [**3-18**] and [**4-17**].
Status post patent ductus arteriosus.
